Eva M Grasa
Universitat Autonoma de Barcelona, Spain
Title: Current and novel cognitive-behavior interventions for resistant schizophrenia
Biography
Biography: Eva M Grasa
Abstract
The aim of this presentation is to review the state of the art regarding cognitive-behavior therapies (CBT) in patients with persistent psychotic symptoms. In many people we observed that core schizophrenia symptoms remain resistant to treatment with medication alone. Including targeted treatment with CBT is widely recommended in clinical practice guidelines, particularly for patients with medication-refractory psychotic experiences. But the heterogeneity and multifaceted nature of psychotic symptoms requires a step forward: the development of specific intervention programmes tailored to target profiles of schizophrenia patients. CBT, when considered a variety of therapies that can be applied in several forms to specific problems and circumstances, would be helpful in increasing psychotherapeutic efficacy. The final result should be the development of specific interventions programs, where multifaceted and individualized formulations addressed to a specific patient could be possible. Third-wave approaches in CBT are example of the benefit from incorporating alternative methods of changing relation between patients and their thoughts and feelings. Scientific evidence of the applicability of such CBT approaches to schizophrenia resistant will be reviewed.
